Table of Contents Author Guidelines Submit a Manuscript
Evidence-Based Complementary and Alternative Medicine
Volume 2016 (2016), Article ID 6134593, 8 pages
http://dx.doi.org/10.1155/2016/6134593
Research Article

Herbal Medicine Cordyceps sinensis Improves Health-Related Quality of Life in Moderate-to-Severe Asthma

1Department of Traditional Chinese Medicine, Xuanwu Hospital, Capital Medical University, 45 Changchun Street, Beijing 100053, China
2Department of Respiratory Medicine, Dongzhimen Hospital of Beijing University of Chinese Medicine, Beijing 100700, China

Received 21 July 2016; Revised 29 October 2016; Accepted 6 November 2016

Academic Editor: Hyunsu Bae

Copyright © 2016 Ningqun Wang et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. K. Samitas, V. Delimpoura, E. Zervas, and M. Gaga, “Anti-IgE treatment, airway inflammation and remodelling in severe allergic asthma: current knowledge and future perspectives,” European Respiratory Review, vol. 24, no. 138, pp. 594–601, 2015. View at Publisher · View at Google Scholar · View at Scopus
  2. J. A. Leff, J. W. Baer, M. E. Bodman, J. M. Kirkman, P. F. Shanley, and L. M. Patton, “Interleukin-1-induced lung neutrophil accumulation and oxygen metabolite-mediated lung leak in rats,” American Journal of Physiology, vol. 266, no. 1, part 1, pp. L2–L8, 1994. View at Google Scholar
  3. J. B. Y. Richman-Eisenstat, P. G. Jorens, C. A. Hebert, I. Ueki, and J. A. Nadel, “Interleukin-8: an important chemoattractant in sputum of patients with chronic inflammatory airway diseases,” American Journal of Physiology—Lung Cellular and Molecular Physiology, vol. 264, no. 4, part 1, pp. L413–L418, 1993. View at Google Scholar · View at Scopus
  4. X. Yang, Y. Li, Y. He et al., “Cordycepin alleviates airway hyperreactivity in a murine model of asthma by attenuating the inflammatory process,” International Immunopharmacology, vol. 26, no. 2, pp. 401–408, 2015. View at Publisher · View at Google Scholar · View at Scopus
  5. J. C. Heo, S. H. Nam, D. Y. Nam, J. G. Kim, K. G. Lee, and J. H. Yeo, “Anti-asthmatic activities in mycelial extract and culture filtrate of Cordyceps sphecocephala J201,” International Journal of Molecular Medicine, vol. 26, no. 3, pp. 351–356, 2010. View at Google Scholar
  6. K. T. Nouri-Aria and S. R. Durham, “Regulatory T cells and allergic disease,” Inflammation and Allergy—Drug Targets, vol. 7, no. 4, pp. 237–252, 2008. View at Publisher · View at Google Scholar · View at Scopus
  7. R. Adams, M. Wakefield, D. Wilson et al., “Quality of life in asthma: a comparison of community and hospital asthma patients,” Journal of Asthma, vol. 38, no. 3, pp. 205–214, 2001. View at Publisher · View at Google Scholar · View at Scopus
  8. E. D. Bateman, D. Esser, C. Chirila et al., “Magnitude of effect of asthma treatments on asthma quality of life questionnaire and asthma control questionnaire scores: systematic review and network meta-analysis,” Journal of Allergy and Clinical Immunology, vol. 136, no. 4, pp. 914–922, 2015. View at Publisher · View at Google Scholar · View at Scopus
  9. Australian Centre for Asthma Monitoring, Asthma in Australia 2011, AIHW Asthma series no 4. Cat.no. ACM 22, AIHW, Canberra, Australia, 2011.
  10. P. G. Gibson, H. Reddel, V. M. McDonald et al., “Effectiveness and response predictors of omalizumab in a severe allergic asthma population with a high prevalence of comorbidities: the Australian Xolair Registry,” Internal Medicine Journal, vol. 46, no. 9, pp. 1054–1062, 2016. View at Publisher · View at Google Scholar
  11. E. F. Juniper, M. E. Wisniewski, F. M. Cox, A. H. Emmett, K. E. Nielsen, and P. M. O'Byrne, “Relationship between quality of life and clinical status in asthma: a factor analysis,” European Respiratory Journal, vol. 23, no. 2, pp. 287–291, 2004. View at Publisher · View at Google Scholar · View at Scopus
  12. K. Ohta, M. Ichinose, Y. Tohda et al., “Long-term once-daily tiotropium Respimat® is well tolerated and maintains efficacy over 52 weeks in patients with symptomatic asthma in Japan: a randomised, placebo-controlled study,” PLoS ONE, vol. 10, no. 4, Article ID e0124109, 2015. View at Publisher · View at Google Scholar · View at Scopus
  13. T. Lai, S. Wang, Z. Xu et al., “Long-term efficacy and safety of omalizumab in patients with persistent uncontrolled allergic asthma: a systematic review and meta-analysis,” Scientific Reports, vol. 5, article 8191, 2015. View at Google Scholar
  14. E. D. Bateman, H. A. Boushey, J. Bousquet et al., “Can guideline-defined asthma control be achieved? The gaining optimal asthma control study,” American Journal of Respiratory and Critical Care Medicine, vol. 170, no. 8, pp. 836–844, 2004. View at Publisher · View at Google Scholar · View at Scopus
  15. M. R. Partridge, R. W. Dal Negro, and D. Olivieri, “Understanding patients with asthma and COPD: insights from a European study,” Primary Care Respiratory Journal, vol. 20, no. 3, pp. 315–323, 2011. View at Publisher · View at Google Scholar · View at Scopus
  16. C. B. Sy and M. C. Siracusa, “The therapeutic potential of targeting cytokine allarmins to treat allergic airway inflammation,” Frontiers in Physiology, vol. 7, article 214, 2016. View at Google Scholar
  17. J. M. Foster, R. Sanderman, T. van der Molen, T. Mueller, and E. van Sonderen, “Personality influences the reporting of side effects of inhaled corticosteroids in asthma patients,” Journal of Asthma, vol. 45, no. 8, pp. 664–669, 2008. View at Publisher · View at Google Scholar · View at Scopus
  18. J. Ko, J. I. Lee, A. Muñoz-Furlong, X.-M. Li, and S. H. Sicherer, “Use of complementary and alternative medicine by food-allergic patients,” Annals of Allergy, Asthma and Immunology, vol. 97, no. 3, pp. 365–369, 2006. View at Publisher · View at Google Scholar · View at Scopus
  19. C. Hassed, “An integrative approach to asthma,” Australian Family Physician, vol. 34, no. 7, pp. 573–576, 2005. View at Google Scholar · View at Scopus
  20. L. Bielory, J. Russin, and G. B. Zuckerman, “Clinical efficacy, mechanisms of action, and adverse effects of complementary and alternative medicine therapies for asthma,” Allergy and Asthma Proceedings, vol. 25, no. 5, pp. 283–291, 2004. View at Google Scholar · View at Scopus
  21. C.-H. Hsu, H.-L. Sun, J.-N. Sheu et al., “Effects of the immunomodulatory agent Cordyceps militaris on airway inflammation in a mouse asthma model,” Pediatrics and Neonatology, vol. 49, no. 5, pp. 171–178, 2008. View at Publisher · View at Google Scholar · View at Scopus
  22. C. Zhang, X. Zou, G. Leluo, J. Xu, and M. Xiang, “Prevention of type 1 diabetes by immature dendritic cells treated with an ethanol extract of Paecilomyces hepiali Chen mycelium,” Methods and Findings in Experimental and Clinical Pharmacology, vol. 30, no. 6, pp. 421–429, 2008. View at Publisher · View at Google Scholar · View at Scopus
  23. J. Y. Oh, Y. M. Baek, S. W. Kim et al., “Apoptosis of human hepatocarcinoma (HepG2) and neuroblastoma (SKN-SH) cells induced by polysaccharides-peptide complexes produced by submerged mycelial culture of an entomopathogenic fungus Cordyceps sphecocephala,” Journal of Microbiology and Biotechnology, vol. 18, no. 3, pp. 512–519, 2008. View at Google Scholar
  24. J.-H. Koh, J.-M. Kim, U.-J. Chang, and H.-J. Suh, “Hypocholesterolemic effect of hot-water extract from mycelia of Cordyceps sinensis,” Biological and Pharmaceutical Bulletin, vol. 26, no. 1, pp. 84–87, 2003. View at Publisher · View at Google Scholar · View at Scopus
  25. H. G. Kim, B. Shrestha, S. Y. Lim et al., “Cordycepin inhibits lipopolysaccharide-induced inflammation by the suppression of NF-κB through Akt and p38 inhibition in RAW 264.7 macrophage cells,” European Journal of Pharmacology, vol. 545, no. 2-3, pp. 192–199, 2006. View at Publisher · View at Google Scholar · View at Scopus
  26. E. L. Y. Wong, R. Y. T. Sung, T. F. Leung et al., “Randomized, double-blind, placebo-controlled trial of herbal therapy for children with asthma,” Journal of Alternative and Complementary Medicine, vol. 15, no. 10, pp. 1091–1097, 2009. View at Publisher · View at Google Scholar · View at Scopus
  27. M. P. F. Barbaro, A. Spanevello, G. P. Palladino, F. G. Salerno, D. Lacedonia, and G. E. Carpagnano, “Exhaled matrix metalloproteinase-9 (MMP-9) in different biological phenotypes of asthma,” European Journal of Internal Medicine, vol. 25, no. 1, pp. 92–96, 2014. View at Publisher · View at Google Scholar · View at Scopus
  28. M. Raundhal, C. Morse, A. Khare et al., “High IFN-γ and low SLPI mark severe asthma in mice and humans,” The Journal of Clinical Investigation, vol. 125, no. 8, pp. 3037–3050, 2015. View at Publisher · View at Google Scholar · View at Scopus
  29. C. Ito, K. Okuyama-Dobashi, T. Miyasaka et al., “CD8+ T cells mediate female-dominant IL-4 production and airway inflammation in allergic asthma,” PLoS ONE, vol. 10, no. 10, Article ID e0140808, 2015. View at Publisher · View at Google Scholar · View at Scopus
  30. M. Tang and L. Fiscus, “Important roles for L-selectin and ICAM-1 in the development of allergic airway inflammation in asthma,” Pulmonary Pharmacology & Therapeutics, vol. 14, no. 3, pp. 203–210, 2001. View at Publisher · View at Google Scholar
  31. E. F. Juniper, A. S. Buist, F. M. Cox, P. J. Ferrie, and D. R. King, “Validation of a standardized version of the asthma quality of life questionnaire,” Chest, vol. 115, no. 5, pp. 1265–1270, 1999. View at Publisher · View at Google Scholar · View at Scopus
  32. M. R. Miller, J. Hankinson, V. Brusasco et al., “Standardisation of spirometry,” European Respiratory Journal, vol. 26, no. 2, pp. 319–338, 2005. View at Publisher · View at Google Scholar · View at Scopus
  33. E. F. Juniper, C. Jenkins, M. J. Price, and M. H. James, “Impact of inhaled salmeterol/fluticasone propionate combination product versus budesonide on the health-related quality of life of patients with asthma,” American Journal of Respiratory Medicine, vol. 1, no. 6, pp. 435–440, 2002. View at Publisher · View at Google Scholar · View at Scopus
  34. C. H. Wei, M. C. Wen, and N. Yu, “Clinical effect of chaipo granule combined with routine treatment on refractory asthma,” Zhongguo Zhong Xi Yi Jie He Za Zhi, vol. 31, pp. 33–36, 2009. View at Google Scholar
  35. M. Liu, G. Y. Liu, S. Y. Hu et al., “Treatment of mild-to-moderate bronchial asthma (heat wheezing syndrome) patients at acute onset with western medicine combined Danlong Oral Liquid: a multi-center, randomized double- blinded, positive-controlled clinical trial,” Zhongguo Zhong Xi Yi Jie He Za Zhi, vol. 35, pp. 529–533, 2015. View at Google Scholar
  36. Z. Wang, J. Yang, and X. Gong, “Effects of Qingfei Pingchuan Bushen Granules on 144 cases of asthma mild duration,” China Journal of Traditional Chinese Medicine and Pharmacy, vol. 28, pp. 351–353, 2013. View at Google Scholar
  37. Z. Yang, L. Wu, and L. Huan, “Comprehensive therapy for 32 cases of chronic persistant and stable asthma,” Practical Clinical Medicine, vol. 10, pp. 28–29, 2009. View at Google Scholar
  38. B. Tang, K. Shi, X. Li et al., “Effect of ‘Yang-warming and kidney essence-replenishing’ herbal paste on cold-related asthma exacerbation,” Journal of Traditional Chinese Medicine, vol. 33, no. 4, pp. 468–472, 2013. View at Publisher · View at Google Scholar · View at Scopus
  39. J.-S. Choi, A.-S. Jang, J.-H. Lee et al., “Effect of high dose inhaled glucocorticoids on quality of life in patients with moderate to severe asthma,” Journal of Korean Medical Science, vol. 20, no. 4, pp. 586–590, 2005. View at Publisher · View at Google Scholar · View at Scopus
  40. P. D. Freitas, P. G. Ferreira, A. da Silva et al., “The effects of exercise training in a weight loss lifestyle intervention on asthma control, quality of life and psychosocial symptoms in adult obese asthmatics: protocol of a randomized controlled trial,” BMC Pulmonary Medicine, vol. 15, no. 1, article 124, 2015. View at Publisher · View at Google Scholar · View at Scopus
  41. S. Turner, P. Eastwood, A. Cook, and S. Jenkins, “Improvements in symptoms and quality of life following exercise training in older adults with moderate/severe persistent asthma,” Respiration, vol. 81, no. 4, pp. 302–310, 2011. View at Publisher · View at Google Scholar · View at Scopus
  42. Z. Kai, L. Yongjian, G. Sheng, and L. Yu, “Effect of Dongchongxiacao (Cordyceps) therapy on contrast-induced nephropathy in patients with type 2 diabetes and renal insufficiency undergoing coronary angiography,” Journal of Traditional Chinese Medicine, vol. 35, no. 4, pp. 422–427, 2015. View at Publisher · View at Google Scholar
  43. K. Zhao, Y. Li, and H. Zhang, “Role of Dongchongxiacao (Cordyceps) in prevention of contrast-induced nephropathy in patients with stable angina pectoris,” Journal of Traditional Chinese Medicine, vol. 33, no. 3, pp. 283–286, 2013. View at Publisher · View at Google Scholar · View at Scopus
  44. S. Chen, Z. Li, R. Krochmal, M. Abrazado, W. Kim, and C. B. Cooper, “Effect of Cs-4® (Cordyceps sinensis) on exercise performance in healthy older subjects: a double-blind, placebo-controlled trial,” Journal of Alternative and Complementary Medicine, vol. 16, no. 5, pp. 585–590, 2010. View at Publisher · View at Google Scholar · View at Scopus
  45. L. R. Bucci, “Selected herbals and human exercise performance,” The American Journal of Clinical Nutrition, vol. 72, no. 2, supplement, pp. 624S–636S, 2000. View at Google Scholar
  46. C. Steurer-Stey, E. W. Russi, and J. Steurer, “Complementary and alternative medicine in asthma: do they work?” Swiss Medical Weekly, vol. 132, no. 25-26, pp. 338–344, 2002. View at Google Scholar
  47. R. M. Locksley, “Asthma and allergic inflammation,” Cell, vol. 140, no. 6, pp. 777–783, 2010. View at Publisher · View at Google Scholar · View at Scopus
  48. L. A. Pinto, M. Depner, N. Klopp et al., “MMP-9 gene variants increase the risk for non-atopic asthma in children,” Respiratory Research, vol. 11, article 23, 2010. View at Publisher · View at Google Scholar · View at Scopus
  49. D. Bourboulia and W. G. Stetler-Stevenson, “Matrix metalloproteinases (MMPs) and tissue inhibitors of metalloproteinases (TIMPs): positive and negative regulators in tumor cell adhesion,” Seminars in Cancer Biology, vol. 20, no. 3, pp. 161–168, 2010. View at Publisher · View at Google Scholar · View at Scopus
  50. D. Mehra, D. I. Sternberg, Y. Jia et al., “Altered lymphocyte trafficking and diminished airway reactivity in transgenic mice expressing human MMP-9 in a mouse model of asthma,” American Journal of Physiology—Lung Cellular and Molecular Physiology, vol. 298, no. 2, pp. L189–L196, 2010. View at Publisher · View at Google Scholar · View at Scopus
  51. E. S. Han, J. Y. Oh, and H.-J. Park, “Cordyceps militaris extract suppresses dextran sodium sulfate-induced acute colitis in mice and production of inflammatory mediators from macrophages and mast cells,” Journal of Ethnopharmacology, vol. 134, no. 3, pp. 703–710, 2011. View at Publisher · View at Google Scholar · View at Scopus
  52. Y.-C. Kuo, W.-J. Tsai, J.-Y. Wang, S.-C. Chang, C.-Y. Lin, and M.-S. Shiao, “Regulation of bronchoalveolar lavage fluids cell function by the immunomodulatory agents from Cordyceps sinensis,” Life Sciences, vol. 68, no. 9, pp. 1067–1082, 2001. View at Publisher · View at Google Scholar · View at Scopus